Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alefacept in de novo kidney transplantation
NCT00617604Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Dec 2007
- Primary completion
- Sep 2009
- Modality
- Fc-Fusion Proteins
- Countries
- 12
01
Overview
A Phase 2 trial of alefacept in kidney transplant rejection, sponsored by Astellas Pharma. Started Dec 2007; status: completed.
02
Drugs
alefacept
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00617604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00617604.